30.05
+0(+0.00%)
Currency In USD
| Previous Close | 30.05 |
| Open | 30.24 |
| Day High | 30.44 |
| Day Low | 29.39 |
| 52-Week High | 35.72 |
| 52-Week Low | 16.1 |
| Volume | 2.77M |
| Average Volume | 2.43M |
| Market Cap | 3.8B |
| PE | -16.42 |
| EPS | -1.83 |
| Moving Average 50 Days | 25.76 |
| Moving Average 200 Days | 23.1 |
| Change | 0 |
If you invested $1000 in Apellis Pharmaceuticals, Inc. (APLS) since IPO date, it would be worth $2,141.84 as of October 30, 2025 at a share price of $30.05. Whereas If you bought $1000 worth of Apellis Pharmaceuticals, Inc. (APLS) shares 5 years ago, it would be worth $942.01 as of October 30, 2025 at a share price of $30.05.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week
GlobeNewswire Inc.
Oct 20, 2025 11:00 AM GMT
Significant proteinuria reduction maintained at one year, regardless of immunosuppressant use or baseline proteinuria levels Complete proteinuria remission (UPCR ≤0.5 g/g) achieved in one-third of patients and sustained through one yearTwo indirect t
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Oct 16, 2025 11:00 AM GMT
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and we
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Aug 27, 2025 11:00 AM GMT
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences: Wells Fargo Healthcare Conference Date/